Develops, produces and licenses natural products, such as quassinoids and taxanes. Includes introduction to targeted oncology, investment data and profile of company in Boulder, Colorado. (Nasdaq: NPRO)

Developing tumor-derived activated cell technology for therapy and vaccines. Overview of principles and contacts in Thomasville Georgia, USA.

Developing diagnostics to identify biomarker fingerprints for ovarian, breast, lung, prostate, and pancreatic cancer. Includes overview of company in Vacaville, California.

Developing vaccines and monoclonal antibodies to delay formation of metastases of epithelial origin. Includes progress of clinical trials and invetor data for company in Vienna, Austria.

Researches and develops therapy products and vaccines for the prevention and treatment of tumors and leukema. Based in San Diego, California. (Nasdaq: MAXM)

Researches and develops novel therapeutic and diagnostic products to treat chronic debilitating diseases such as cancer, central nervous system disorders and autoimmune diseases. Based in Massachusetts. (Nasdaq: BLSI).

Develops organic chemistry and immunotherapy technology to produce synthetic therapeutic vaccines targeting proliferative tumors. Resources for patients and professionals and investors, with profile of company based in Edmonton, Alberta. (Nasdaq: BIOM)

Develops and commercializes innovative small molecule drugs, initially for improving cancer treatments. Based in Westminster, Colorado. (Nasdaq: ALTH)

Develops diagnostics and treatments of cancer, with skeletal targeted radiotherapy. Includes information for investors, partnering and licensing, with manufacture in Texas and headquarters in Seattle, Washington. (Nasdaq: NERX)

Develops pharmaceuticals relating to anti-cancer therapeutics. Includes product portfolio, with clinical trials and licensing details, conferences, international careers from San Antonio, Texas. (Nasdaq: ILXO).